Primary Site >> Liver Cancer
Gene >> CDKN3
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma. PMID: 10987270 |
Ref: Involvement of PKC betaII in anti-proliferating action of a new antitumor compound gnidimacrin. PMID: 12740906 Ref: Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant. PMID: 12745075 |
Ref: Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation. PMID: 21535270 Ref: Altered expression of GADD45 genes during the development of chemical-mediated liver hypertrophy and liver tumor promotion in rats. PMID: 22008536 |
Ref: Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation. PMID: 22390936 Ref: Functional and topological properties in hepatocellular carcinoma transcriptome. PMID: 22539975 |
Ref: Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth. PMID: 23292002 |
Ref: CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma. PMID: 27314282 |
Ref: Choline, Other Methyl-Donors and Epigenetics. PMID: 28468239 |
Ref: Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis. PMID: 29670361 Ref: Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches. PMID: 29843214 Ref: Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma. PMID: 29962817 |